Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1/2 1Phase 1 1

Status

Completed 4Withdrawn 2Unknown 1

Sponsor Class

OTHER 7NIH 2INDUSTRY 2

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 3NET 1Lymphoid 1Endocrine 1

Conditions

Polycystic Ovary Syndrome 1Neuroendocrine Tumors 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphangioleiomyomatosis 1Liver Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Colorectal Neoplasms 1Colonic Neoplasms 1Chemoprevention 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × Interventional × Resveratrol × Clear all
NCT04266353 2023-05-09

Effect of Resveratrol on Serum IGF2 Among African American Women

Loma Linda University

Phase NA Withdrawn

Chemoprevention

NCT03253913 2023-02-01

RESULT

University of Cincinnati

Phase 2 Completed
25 enrolled 11 charts

Lymphangioleiomyomatosis

NCT04867252 2021-09-13

Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

Khyber Medical University Peshawar

Phase 2 Completed
88 enrolled

Polycystic Ovary Syndrome

NCT01476592 2019-11-18

A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors

University of Wisconsin, Madison

Phase NA Completed
7 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT02261844 2017-03-30

Resveratrol and Human Hepatocyte Function in Cancer

University of Louisville

Phase 1/2 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Colorectal Neoplasms

NCT00256334 2014-06-20

Resveratrol for Patients With Colon Cancer

University of California, Irvine

Phase 1 Completed
11 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown
45 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡